There's A Pharma Waiting In The Sky: Lilly In Space
NASA's orbiting laboratory on the International Space Station has allowed researchers from drug manufacturers like Eli Lilly & Co. to find solutions in space to certain obstacles they've struggled with on Earth, potentially helping the firms get their investigational medicines to the marketplace sooner.
You may also be interested in...
While the goal of the yearlong mission aboard the International Space Station (ISS) involving US astronaut Scott Kelly and his Russian counterpart cosmonaut Mikhail Kornienko, who both returned to Earth on March 2, was intended to examine the effects of microgravity on the human body with the aim of reducing the health risks on future crewmembers, NASA serendipitously fell into a fortuitous situation to study spaceflight at the molecular level, potentially providing the life sciences sector a wealth of data – an opportunity that may not come around again for quite some time, if at all.
Space is waiting for you pharma. So come on and take a free ride – literally.
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.